260 related articles for article (PubMed ID: 34518312)
1. Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non-Small Cell Lung Cancer.
Porciuncula A; Morgado M; Gupta R; Syrigos K; Meehan R; Zacharek SJ; Frederick JP; Schalper KA
Clin Cancer Res; 2021 Nov; 27(22):6174-6183. PubMed ID: 34518312
[TBL] [Abstract][Full Text] [Related]
2. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
3. High Serum OX40 and OX40 Ligand (OX40L) Levels Correlate with Reduced Survival in Patients with Advanced Lung Adenocarcinoma.
Kashima J; Okuma Y; Hosomi Y; Hishima T
Oncology; 2020; 98(5):303-310. PubMed ID: 32097938
[TBL] [Abstract][Full Text] [Related]
4. OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers.
He Y; Zhang X; Jia K; Dziadziuszko R; Zhao S; Deng J; Wang H; Hirsch FR; Zhou C
Transl Lung Cancer Res; 2019 Aug; 8(4):352-366. PubMed ID: 31555511
[TBL] [Abstract][Full Text] [Related]
5. Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia.
Cui D; Lv Y; Yuan X; Ruan G; Zhang Y; Yan C; Xu D; Lv M; Mao Y; Cao J; Jin J; Xie J
J Immunol Res; 2019; 2019():6804806. PubMed ID: 30944836
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment.
Chen P; Wang H; Zhao L; Guo H; Zhang L; Zhang W; Sun C; Zhao S; Li W; Zhu J; Yu J; Wu C; He Y
Front Oncol; 2021; 11():713853. PubMed ID: 34900670
[TBL] [Abstract][Full Text] [Related]
7. [Expressions and clinical significance of OX40 and OX40L in peripheral blood of patients with primary Sjogren's syndrome].
Zhu R; Jiang J; Wang T; Xu T; Wu M; Liu C; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):862-5. PubMed ID: 23948416
[TBL] [Abstract][Full Text] [Related]
8. OX40 and OX40L Interaction in Cancer.
Lu X
Curr Med Chem; 2021; 28(28):5659-5673. PubMed ID: 33372866
[TBL] [Abstract][Full Text] [Related]
9. Expression and Clinical Significance of OX40 and OX40L mRNA in Hepatocellular Carcinoma.
Du P; Wang Z; Geng J; Wang Y
Bull Exp Biol Med; 2021 Feb; 170(4):485-488. PubMed ID: 33713232
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma.
Chen X; Ma H; Mo S; Zhang Y; Lu Z; Yu S; Chen J
Front Immunol; 2022; 13():942154. PubMed ID: 35936015
[TBL] [Abstract][Full Text] [Related]
11. Critical role of OX40/OX40L in ILC2-mediated activation of CD4
Wu J; Cui Y; Zhu W; Bai S; Zhao N; Liu B
Int Immunopharmacol; 2019 Nov; 76():105784. PubMed ID: 31470268
[TBL] [Abstract][Full Text] [Related]
12. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
[TBL] [Abstract][Full Text] [Related]
13. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
14. OX40, OX40L and Autoimmunity: a Comprehensive Review.
Webb GJ; Hirschfield GM; Lane PJ
Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
[TBL] [Abstract][Full Text] [Related]
15. In Situ Reprogramming of Tumors for Activating the OX40/OX40 Ligand Checkpoint Pathway and Boosting Antitumor Immunity.
Gao Y; Zhao J; Huang Z; Zhao H; Guo Z; Ma S; Tang X; Song W; Chen X
ACS Biomater Sci Eng; 2023 Jul; 9(7):4108-4116. PubMed ID: 35653749
[TBL] [Abstract][Full Text] [Related]
16. OX40-OX40L expression in idiopathic inflammatory myopathies.
Papadopoulos C; Terzis G; Papadimas GK; Manta P
Anal Quant Cytopathol Histpathol; 2013 Feb; 35(1):17-26. PubMed ID: 23469620
[TBL] [Abstract][Full Text] [Related]
17. Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts.
Afaneh C; Muthukumar T; Lubetzky M; Ding R; Snopkowski C; Sharma VK; Seshan S; Dadhania D; Schwartz JE; Suthanthiran M
Transplantation; 2010 Dec; 90(12):1381-7. PubMed ID: 21079547
[TBL] [Abstract][Full Text] [Related]
18. Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand.
Baba E; Takahashi Y; Lichtenfeld J; Tanaka R; Yoshida A; Sugamura K; Yamamoto N; Tanaka Y
J Immunol; 2001 Jul; 167(2):875-83. PubMed ID: 11441094
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis.
Zhou X; Wang X; Gu Y; Chen L; Shen Y; Tian J; Shujun C; Wang M; Duan X; Gao H; Ji X; Fang Q; Zhang X; Xue Q
J Immunol Res; 2022; 2022():4337399. PubMed ID: 35265719
[TBL] [Abstract][Full Text] [Related]
20. Relative Expression of OX40, OX40L mRNA, and OX40L Serum Levels in Women with Recurrent Spontaneous Abortion.
Rahmani F; Hadinedoushan H; Ghasemi N
Immunol Invest; 2019 Jul; 48(5):480-489. PubMed ID: 30794011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
